Skip to content
healthcare.dev

valganciclovir hydrochloride

NDC 43598-356, valganciclovir hydrochloride, tablet, from Dr. Reddy's Laboratories Inc.

Product NDC
43598-356
Status
Listed
Labeler
Dr. Reddy's Laboratories Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206876
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-356 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VALGANCICLOVIR HYDROCHLORIDE450 mg/1

Pharmacologic classes

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
43598-356-304359803563030 TABLET in 1 BOTTLE (43598-356-30)
43598-356-604359803566060 TABLET in 1 BOTTLE (43598-356-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e30ae2b2-dad2-39ba-6bc7-400807791ab0

Use it

Look up 43598-356 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-356 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-356. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.